CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: August 23, 2011
Result type: Reports
Project Number: SR0246-000
Product Line: Reimbursement Review

Generic Name: Exenatide

Brand Name: Byetta

Manufacturer: Eli Lilly Canada

Therapeutic Area: Diabetes mellitus, type 2

Indications: Diabetes mellitus, Type 2

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 19, 2012

Recommendation Type: Do not list